0001232524-17-000115.txt : 20170515
0001232524-17-000115.hdr.sgml : 20170515
20170515172652
ACCESSION NUMBER: 0001232524-17-000115
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170511
FILED AS OF DATE: 20170515
DATE AS OF CHANGE: 20170515
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILLER MICHAEL PATRICK
CENTRAL INDEX KEY: 0001236514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 17846024
BUSINESS ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD
CITY: DUBLIN 4
STATE: L2
ZIP: 0
BUSINESS PHONE: 6504963552
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD
CITY: DUBLIN 4
STATE: L2
ZIP: 0
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-05-11
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001236514
MILLER MICHAEL PATRICK
5TH FL, WATERLOO EXCHANGE
WATERLOO RD
DUBLIN 4
L2
IRELAND
0
1
0
0
EVP, US Commercial
Ordinary Shares
2017-05-11
4
A
0
1000
0.0
A
22623
D
Ordinary Shares
2017-05-15
4
S
0
200
152.98
D
22423
D
Non-Qualified Stock Option (right to buy)
155.18
2017-05-11
4
A
0
2500
0.0
A
2027-05-10
Ordinary Shares
2500
2500
D
These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of June 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, May 11, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
By: /s/Peter A Christou, as attorney in fact For: Michael Patrick Miller
2017-05-15